Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-04-06

FDA Approved: ZONEGRAN — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

FDA approved a supplemental application for ZONEGRAN (zonisamide) submitted by Advanz Pharma (US) Corp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonegran (zonisamide)

Snippet

SUPPL AP for ZONEGRAN (ZONISAMIDE)